ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018

 

View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.


Bronchiectasis: new insights in diagnosis and treatment

Lunchtime session
Chairs: S. Aliberti (Milan, Italy), E. Grainger (London, United Kingdom)
Aims: The prevalence of bronchiectasis in the United Kingdom increased by 40% between 2004 and 2014. Similar increases have been observed worldwide (European Respiratory Journal 2016 47: 186–193). The rising burden of this disease has led to intense research activity on potential treatments, including multiple randomised controlled trials. Despite this, treatment options remain limited and clinical management is challenging. This joint Lancet/Lancet Respiratory Medicine session aims to give an overview of the latest treatments, clinical developments and cutting-edge research in both adult and paediatric bronchiectasis.
Bronchiectasis: new therapies and perspectives
J. Chalmers (Dundee (Angus), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Diagnosis and management of non-cystic fibrosis bronchiectasis in children
A. Chang (Brisbane (QLD), Australia)
WebcastSlide presentation
WebcastSlide presentation
Advances in bronchiectasis: the microbiome, endotyping, genetics and disease heterogeneity
J. Chalmers (Dundee (Angus), United Kingdom)
No content made available
No content made available
Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis: the  BEST-2 trial
K. Grimwood (Gold Coast (QLD), Australia)
WebcastSlide presentation
WebcastSlide presentation